Fig. 6: Number of agents applied as third-line treatment in multiple myeloma patients, initiation of third-line treatment 2004–2021.
From: Second- and third-line treatment strategies in multiple myeloma: a referral-center experience
ASCT autologous stem cell transplantation.
